Silver Book Fact

AFib, an economic burden

Fact image

AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study estimates that Medicare alone pays $15.7 billion per year to treat newly diagnosed AFib patients.

Lee WC, Lamas GA, Balu S, et al. Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective. J Med Econ. 2008; 11(2). http://www.ncbi.nlm.nih.gov/pubmed/19450086

Coyne KS, Paramore C, Grandy S, et al. Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States. Value in Health. 2006; 9(5). http://www.ncbi.nlm.nih.gov/pubmed/16961553

Reference

Title
Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective
Publication
J Med Econ
Publication Date
2008
Authors
Lee WC, Lamas GA, Balu S, et al
Volume & Issue
Volume 11, Issue 2
Pages
281-98
URL
Read Full Resource
Title
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Publication
Value in Health
Publication Date
2006
Authors
Coyne KS, Paramore C, Grandy S, et al
Volume & Issue
Volume 9, Issue 5
Pages
348-56
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib-related stroke and disability
    Stroke is very disabling and individuals recovering from a stroke who also have AFib have a higher risk of remaining disable or handicapped compared to stroke patients without AFib.  
  • Distribution of inpatient and selected outpatient costs for treating atrial fibrillation
    Distribution of inpatient and selected outpatient costs for treating atrial fibrillation  
  • Atrial fibrillation doubles mortality risk
    Atrial fibrillation is associated with an approximate doubling of mortality risk.  
  • AFib prevalence estimates
    Atrial fibrillation is the most common heart arrhythmia in the U.S. Often going undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans.  
  • Annual direct cost of Afib
    Average annual cost comparison between patients with and without atrial fibrillation